Evaluation of hypertension in systemic sclerosis and systemic lupus erythematosus overlap
- PMID: 36743818
- PMCID: PMC9896192
- DOI: 10.1177/23971983221122673
Evaluation of hypertension in systemic sclerosis and systemic lupus erythematosus overlap
Abstract
Patients with systemic sclerosis and systemic lupus erythematosus serologies present a unique challenge to the clinician when hypertension is detected in the outpatient setting. Treatment choices for non-renal crisis hypertension are different for systemic sclerosis versus systemic lupus erythematosus. Urgent laboratory studies and, in the presence of certain symptoms, imaging assessment are indicated in systemic sclerosis and systemic lupus erythematosus overlap patients with systemic hypertension. Long-term assessment of systemic hypertension may be enhanced by advances in non-contrast imaging that serve as valuable biomarkers for progressive vasculopathy. In this review, the diagnostic approach to systemic sclerosis and systemic lupus erythematosus overlap patients presenting with hypertension is discussed.
Keywords: Systemic sclerosis; hypertension; renal crisis; systemic lupus erythematosus.
© The Author(s) 2022.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.Ann Cardiol Angeiol (Paris). 2019 Oct;68(4):221-225. doi: 10.1016/j.ancard.2018.10.012. Epub 2019 Jan 23. Ann Cardiol Angeiol (Paris). 2019. PMID: 30685083
-
Glomerulonephritis and Coombs-positive hemolytic anemia mimicking scleroderma renal crisis in an overlap of systemic lupus erythematosus and diffuse systemic sclerosis.Rheumatol Int. 2020 May;40(5):785-789. doi: 10.1007/s00296-019-04471-w. Epub 2019 Nov 7. Rheumatol Int. 2020. PMID: 31701184
-
Scleroderma-associated thrombotic microangiopathy in overlap syndrome of systemic sclerosis and systemic lupus erythematosus: A case report and literature review.Medicine (Baltimore). 2020 Oct 9;99(41):e22582. doi: 10.1097/MD.0000000000022582. Medicine (Baltimore). 2020. PMID: 33031308 Free PMC article. Review.
-
Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.J Rheumatol. 2018 Oct;45(10):1406-1410. doi: 10.3899/jrheum.170953. Epub 2018 Jul 15. J Rheumatol. 2018. PMID: 30008448
-
Pulmonary hypertension in systemic lupus erythematosus.Best Pract Res Clin Rheumatol. 2013 Jun;27(3):425-34. doi: 10.1016/j.berh.2013.07.011. Best Pract Res Clin Rheumatol. 2013. PMID: 24238697 Review.
Cited by
-
Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis.J Inflamm Res. 2023 Oct 17;16:4633-4660. doi: 10.2147/JIR.S379815. eCollection 2023. J Inflamm Res. 2023. PMID: 37868834 Free PMC article. Review.
References
-
- Pakozdi A, Nihtyanova S, Moinzadeh P, et al.. Clinical and serological hallmarks of systemic sclerosis overlap syndromes. J Rheumatol 2011; 38(11): 2406–2409. - PubMed
-
- Alharbi S, Ahmad Z, Bookman AA, et al.. Epidemiology and survival of systemic sclerosis-systemic lupus erythematosus overlap syndrome. J Rheumatol 2018; 45(10): 1406–1410. - PubMed
-
- Scherlinger M, Lutz J, Galli G, et al.. Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments. Semin Arthritis Rheum 2021; 51(1): 36–42. - PubMed
-
- Zampaglione B, Pascale C, Marchisio M, et al.. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 1996; 27: 144–147. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources